PT Lippo Karawaci Tbk

PINK:PTLKF USA Medical Care Facilities
Market Cap
$708.77 Million
Market Cap Rank
#12240 Global
#5311 in USA
Share Price
$0.01
Change (1 day)
+0.00%
52-Week Range
$0.01 - $0.01
All Time High
$0.06
About

PT Lippo Karawaci Tbk, together with its subsidiaries, provides property development services in Indonesia. The company operates through Holdco, Real Estate Development, Healthcare, and Lifestyle segments. It is involved in the real estate activities, including urban development; development of facilities and its infrastructure; memorial park, town management, large scale integrated and infrastru… Read more

PT Lippo Karawaci Tbk (PTLKF) - Net Assets

Latest net assets as of June 2025: $31.35 Trillion USD

Based on the latest financial reports, PT Lippo Karawaci Tbk (PTLKF) has net assets worth $31.35 Trillion USD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($54.66 Trillion) and total liabilities ($23.31 Trillion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $31.35 Trillion
% of Total Assets 57.36%
Annual Growth Rate 13.1%
5-Year Change 31.28%
10-Year Change 63.6%
Growth Volatility 22.52

PT Lippo Karawaci Tbk - Net Assets Trend (2005–2024)

This chart illustrates how PT Lippo Karawaci Tbk's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for PT Lippo Karawaci Tbk (2005–2024)

The table below shows the annual net assets of PT Lippo Karawaci Tbk from 2005 to 2024.

Year Net Assets Change
2024-12-31 $30.95 Trillion +57.84%
2023-12-31 $19.61 Trillion +2.44%
2022-12-31 $19.14 Trillion -14.88%
2021-12-31 $22.49 Trillion -4.61%
2020-12-31 $23.57 Trillion -31.42%
2019-12-31 $34.38 Trillion +34.97%
2018-12-31 $25.47 Trillion -14.70%
2017-12-31 $29.86 Trillion +35.27%
2016-12-31 $22.08 Trillion +16.70%
2015-12-31 $18.92 Trillion +7.20%
2014-12-31 $17.65 Trillion +24.47%
2013-12-31 $14.18 Trillion +23.60%
2012-12-31 $11.47 Trillion +21.91%
2011-12-31 $9.41 Trillion +15.03%
2010-12-31 $8.18 Trillion +54.65%
2009-12-31 $5.29 Trillion +8.83%
2008-12-31 $4.86 Trillion +7.18%
2007-12-31 $4.53 Trillion +38.35%
2006-12-31 $3.28 Trillion +9.85%
2005-12-31 $2.98 Trillion --

Equity Component Analysis

This analysis shows how different components contribute to PT Lippo Karawaci Tbk's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1716.2% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings $7.85 Trillion 26.29%
Common Stock $7.09 Trillion 23.74%
Other Comprehensive Income $3.48 Trillion 11.66%
Other Components $11.44 Trillion 38.31%
Total Equity $29.87 Trillion 100.00%

PT Lippo Karawaci Tbk Competitors by Market Cap

The table below lists competitors of PT Lippo Karawaci Tbk ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in PT Lippo Karawaci Tbk's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 15,314,603,000,000 to 29,868,532,000,000, a change of 14,553,929,000,000 (95.0%).
  • Net income of 18,746,045,000,000 contributed positively to equity growth.
  • Share repurchases of 23,726,000,000 reduced equity.
  • Other comprehensive income decreased equity by 4,209,597,000,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $18.75 Trillion +62.76%
Share Repurchases $23.73 Billion -0.08%
Other Comprehensive Income $-4.21 Trillion -14.09%
Other Changes $41.21 Billion +0.14%
Total Change $- 95.03%

Book Value vs Market Value Analysis

This analysis compares PT Lippo Karawaci Tbk's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.00x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2005-12-31 $118.68 $0.01 x
2006-12-31 $148.84 $0.01 x
2007-12-31 $211.32 $0.01 x
2008-12-31 $196.24 $0.01 x
2009-12-31 $224.15 $0.01 x
2010-12-31 $352.89 $0.01 x
2011-12-31 $312.31 $0.01 x
2012-12-31 $370.70 $0.01 x
2013-12-31 $446.10 $0.01 x
2014-12-31 $543.83 $0.01 x
2015-12-31 $571.32 $0.01 x
2016-12-31 $647.23 $0.01 x
2017-12-31 $795.57 $0.01 x
2018-12-31 $653.45 $0.01 x
2019-12-31 $636.01 $0.01 x
2020-12-31 $275.72 $0.01 x
2021-12-31 $264.94 $0.01 x
2022-12-31 $335.37 $0.01 x
2023-12-31 $335.19 $0.01 x
2024-12-31 $653.74 $0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently PT Lippo Karawaci Tbk utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 62.76%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 165.19%
  • • Asset Turnover: 0.21x
  • • Equity Multiplier: 1.80x
  • Recent ROE (62.76%) is above the historical average (5.01%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2005 13.56% 18.21% 0.32x 2.31x $95.90 Billion
2006 11.57% 17.99% 0.22x 2.86x $46.57 Billion
2007 8.76% 17.62% 0.20x 2.50x $-52.13 Billion
2008 8.82% 15.54% 0.22x 2.62x $-53.19 Billion
2009 8.93% 17.02% 0.21x 2.48x $-52.24 Billion
2010 7.71% 19.02% 0.19x 2.10x $-176.47 Billion
2011 8.02% 16.91% 0.23x 2.07x $-175.09 Billion
2012 9.95% 17.21% 0.25x 2.33x $-5.39 Billion
2013 9.59% 18.42% 0.21x 2.45x $-51.86 Billion
2014 16.32% 21.86% 0.31x 2.42x $986.77 Billion
2015 3.27% 6.15% 0.21x 2.52x $-1.10 Trillion
2016 4.75% 8.55% 0.23x 2.46x $-974.83 Billion
2017 2.69% 5.63% 0.19x 2.49x $-1.67 Trillion
2018 3.71% 5.66% 0.25x 2.66x $-1.18 Trillion
2019 -7.16% -16.93% 0.22x 1.91x $-4.94 Trillion
2020 -49.48% -81.60% 0.23x 2.66x $-11.58 Trillion
2021 -8.66% -10.06% 0.31x 2.78x $-3.50 Trillion
2022 -15.19% -15.86% 0.29x 3.25x $-3.86 Trillion
2023 0.33% 0.30% 0.34x 3.24x $-1.48 Trillion
2024 62.76% 165.19% 0.21x 1.80x $15.76 Trillion

Industry Comparison

This section compares PT Lippo Karawaci Tbk's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

  • Industry: Medical Care Facilities
  • Average net assets among peers: $250,407,165
  • Average return on equity (ROE) among peers: -38.80%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
PT Lippo Karawaci Tbk (PTLKF) $31.35 Trillion 13.56% 0.74x $338.52 Million
Addus HomeCare Corporation (ADUS) $113.86 Million 16.82% 0.44x $1.75 Billion
agilon health Inc (AGL) $126.73 Million -319.84% 9.03x $166.17 Million
Airsculpt Technologies Inc (AIRS) $123.68 Million 6.13% 0.45x $16.62 Million
Amedisys Inc (AMED) $454.23 Million -18.40% 0.61x $3.26 Billion
AMN Healthcare Services Inc (AMN) $347.86 Million 23.54% 1.53x $624.22 Million
American Shared Hospital Service (AMS) $20.85 Million 8.48% 1.33x $7.93 Million
American Oncology Network Inc. (AONC) $226.04 Million -0.05% 0.10x $112.23 Million
Ardent Health Partners, Inc. (ARDT) $1.08 Billion 4.65% 3.71x $225.22 Million
Arem Pacific Corporation (ARPC) $-45.09K 0.00% 0.00x $246.12K
Astrana Health Inc (ASTH) $8.55 Million -109.27% 1.29x $1.08 Billion